1 February 2022

Sweden’s National Board of Health and Welfare concluded in February 2022 that, for under-18s as a group, the risks of ho

Name: Sweden’s National Board of Health and Welfare concluded in February 2022 that, for under-18s as a group, the risks of ho
Start: 2022-02-01
Location: Europe

Sweden’s National Board of Health and Welfare concluded in February 2022 that, for under-18s as a group, the risks of hormonal treatment then outweighed its possible benefits.

Source: The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets (Journal of Sexual Medicine, 2018)

Jurisdiction: Europe

Read the dossier on this country